U.S. markets closed

Pulse Biosciences, Inc. (6L8.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
3.7800-0.1400 (-3.57%)
At close: 03:44PM CEST

Pulse Biosciences, Inc.

3957 Point Eden Way
Hayward, CA 94545
United States
510 906 4600

IndustryMedical Instruments & Supplies
Full Time Employees61

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert W. DugganExec. ChairmanN/AN/A1945
Mr. Kevin DanahyChief Exec. Officer393.25kN/A1971
Mr. Darrin R. UeckerCTO & Director487.24kN/A1966
Mr. Mitchell E. LevinsonChief Strategy Officer361.34kN/A1960
Dr. Richard Nuccitelli Ph.D.Chief Science OfficerN/AN/AN/A
Mr. Kenneth B. Stratton Esq., J.D.Gen. Counsel & Corp. Sec.N/AN/A1969
Ms. Patty PerlaVP of HRN/AN/AN/A
Mr. David DanitzSr. VP of EngineeringN/AN/AN/A
Dr. Gansevoort Dunnington M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Corporate Governance

Pulse Biosciences, Inc.’s ISS Governance QualityScore as of September 1, 2023 is 7. The pillar scores are Audit: 3; Board: 9; Shareholder Rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.